eli lilly's tirzepatide is the leader in weight loss sector Diabetes drug tested for could be game changer Lilly's Weight-Loss Drug Is a

Never restart semaglutide without medical clearance after surgery

It works by simultaneously activating three incretin-related receptors: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor

Research shows that obesity is linked to infertility, so moving toward a healthy weight with the help of Ozempic may improve your chances of getting pregnant

Tirzepatide has not been linked to an increased risk of cancer in any clinical studies

Beyond weight loss, the trial also found improvements in physical function

Multiple lawsuits have been filed against Novo Nordisk alleging that semaglutide caused blood clots